Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-11-02

FDA Approved: NAPROXEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for Naproxen by Amneal Pharmaceuticals of New York LLC (generic Naproxen).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxen (Naproxen)

Snippet

SUPPL AP for NAPROXEN (NAPROXEN)